Clinical Trials Directory

Trials / Completed

CompletedNCT05809466

The Effect of a 12-week Self-composed Vegan Diet With or Without Concurrent Resistance Exercise on Thigh Muscle Volume in Older Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
72 (actual)
Sponsor
Wageningen University · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

Consumers are increasingly encouraged to consume more plant-based foods and lower their consumption of foods from animal origin. This shift is driven by environmental and health factors. However, the consequences of such a transition on muscle mass still remains to be explored. This is of particular importance in the older population, where the age-related reduction in muscle mass and strength is highly prevalent. Adequate dietary intake, specifically protein intake, is a well-known strategy in promoting muscle mass in older adults. Plant-based foods are currently considered to be inferior to animal-based foods in their protein quality, and are therefore considered to be suboptimal for the maintenance of muscle mass at an older age. On the other hand, combining plant-based foods may improve the protein quality and thereby the anabolic properties of a vegan meal. Evidence regarding the anabolic properties of vegan diets in older adults is scarce. As such, the current study aims to assess 1) the effects of a 12-week self-composed vegan diet in comparison to an omnivorous diet on thigh muscle volume (TMV) in community-dwelling older adults and 2) the effect of a 12-week self-composed vegan diet combined with twice-weekly resistance exercise (RE) on TMV in comparison to a self-composed vegan diet without resistance exercise in community-dwelling older adults.

Conditions

Interventions

TypeNameDescription
OTHERVegan dietA self-composed 12 week fully plant-based diet
OTHERResistance exerciseBiweekly resistance exercise for 12 weeks
OTHEROmnivorous dietHabitual diet containing both animal- and plant-based food products

Timeline

Start date
2023-04-04
Primary completion
2024-09-26
Completion
2024-09-26
First posted
2023-04-12
Last updated
2025-04-01

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05809466. Inclusion in this directory is not an endorsement.